Abstract
Objective: To evaluate the safety and efficacy of tisotumab vedotin-tftv (TV), a first-in-class vectorized anti-tissue factor (TF) antibody-drug conju......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
